A catalytic mechanism for caspase-1 and for bimodal inhibition of caspase-1 by activated aspartic ketones
- 8 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 7 (4) , 621-631
- https://doi.org/10.1016/s0968-0896(99)00009-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- α-((Tetronoyl)oxy)- and α-((tetramoyl)oxy)methyl ketone inhibitors of the interleukin-1β converting enzyme (ICE)Bioorganic & Medicinal Chemistry Letters, 1997
- Inhibition of interleukin-1β converting enzyme by N-acyl-aspartyl aryloxymethyl ketonesBioorganic & Medicinal Chemistry Letters, 1995
- Aspartyl .alpha.-((1-Phenyl-3-(trifluoromethyl)- pyrazol-5-yl)oxy)methyl Ketones as Interleukin-1.beta. Converting Enzyme Inhibitors. Significance of the P1 and P3 Amido Nitrogens for Enzyme-Peptide Inhibitor BindingJournal of Medicinal Chemistry, 1994
- Activated ketones as potent reversible inhibitors of interleukin-Iβ converting enzymeBioorganic & Medicinal Chemistry Letters, 1994
- Inactivation of Interleukin-1.beta. Converting Enzyme by Peptide (Acyloxy)methyl KetonesBiochemistry, 1994
- Potent Inactivation of Cathepsins S and L by Peptidyl (Acyloxy)methyl KetonesBiological Chemistry Hoppe-Seyler, 1994
- Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinasesBiochemical Journal, 1992
- Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinasesBiochemistry, 1991
- New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategyJournal of the American Chemical Society, 1988
- Pharmaceutical SaltsJournal of Pharmaceutical Sciences, 1977